News

Potential New Treatment for Advanced HCC Went Through Successful Phase 1 and Phase 2 Studies

31/07/2019

× CLOSE

Potential New Treatment for Advanced HCC Went Through Successful Phase 1 and Phase 2 Studies

31/07/2019

Successful Study on New Drug for Chronic Lymphocytic Leukemia (CLL) Paves Way for Phase 2 Study on Efficacy and Safety of the Selected Dosage

24/07/2019

× CLOSE

Successful Study on New Drug for Chronic Lymphocytic Leukemia (CLL) Paves Way for Phase 2 Study on Efficacy and Safety of the Selected Dosage

24/07/2019

Study Shows New Drugs for Hepatitis C Well-Tolerated in Chinese Participants

24/07/2019

× CLOSE

Study Shows New Drugs for Hepatitis C Well-Tolerated in Chinese Participants

24/07/2019

Phase 1 Study Shows Effective Antiviral Response of Novel Drug for Hepatitis B Virus (HBV)

24/07/2019

× CLOSE

Phase 1 Study Shows Effective Antiviral Response of Novel Drug for Hepatitis B Virus (HBV)

24/07/2019

Immunotherapy Drug Proven More Effective Than Traditional Sorafenib Treatment for HCC Patients

24/07/2019

× CLOSE

Immunotherapy Drug Proven More Effective Than Traditional Sorafenib Treatment for HCC Patients

24/07/2019

Potential New Treatment for Advanced HCC Went Through Successful Phase 1 and Phase 2 Studies

24/07/2019

× CLOSE

Potential New Treatment for Advanced HCC Went Through Successful Phase 1 and Phase 2 Studies

24/07/2019

[Study Completion] Successful Completion of a Generic drug!

10/07/2019

× CLOSE

[Study Completion] Successful Completion of a Generic drug!

10/07/2019

[Centre Activity] HKU/QMH Completed NMPA Re-inspection and Received Clinical Trials Accreditation in a Total of 14 Clinical Specialties/Areas

25/06/2019

× CLOSE

[Centre Activity] HKU/QMH Completed NMPA Re-inspection and Received Clinical Trials Accreditation in a Total of 14 Clinical Specialties/Areas

25/06/2019

National Medical Products Administration (NMPA, previously called China Food and Drug Administration) visited Queen Mary Hospital on 29th April, 2019 for re-inspection on 14 clinical specialties (including HKU Phase 1 Clinical Trials Centre, cardiology, endocrinology & metabolism, respiratory medicine, hepatobiliary & pancreatic surgery and liver transplantation, obstetrics & gynaecology, haematology & bone marrow transplantation, neurology, nephrology, clinical immunology, orthopaedics & traumatology, gastroenterology & hepatology, oncology and paediatrics & adolescent medicine). The overall inspection result was satisfactory and the said specialties successfully received the continuing accreditation by the NMPA, meaning that the clinical drug trial data from these specialties are acceptable by the NMPA for evaluation of new drug approval applications.

HKU/QMH has been accredited by the NMPA for conducting clinical drug trials in six clinical specialties since 2006. HKU Phase 1 Clinical Trials Centre and seven additional clinical specialties were further accredited in July 2016.

[Centre Activity] Chinese New Year Booth at Queen Mary Hospital

30/01/2019

× CLOSE

[Centre Activity] Chinese New Year Booth at Queen Mary Hospital

30/01/2019

HKU-CTC set up a Chinese New Year Booth at Queen Mary Hospital on 30th January, 2019 to share the joy and happiness with the public. Information panels with introduction of clinical trials were displayed. Other than that, Dr. Hong, one of the CTC Panda Ambassadors, visited the booth on that day. He gave out red packets and fai-chuns to the supporters. It attracted many visitors to come and learn more about clinical trials. Here are some highlights of the event:

[Centre Activity] HKU-CTC 20th Anniversary Ceremony & Gala Dinner

28/11/2018

× CLOSE

[Centre Activity] HKU-CTC 20th Anniversary Ceremony & Gala Dinner

28/11/2018

HKU-CTC’s 20th Anniversary Ceremony and Gala Dinner was successfully held on 7th November, 2018. The event was the grand finale of a series of anniversary activities during 2018. Some 200 prominent officials, academia, healthcare practitioners, clinical research professionals and industrial representatives joined us in reviewing HKU-CTC’s 20 years of ground-breaking journey in clinical research and gave their heartfelt greetings in Loke Yew Hall, a historic landmark of HKU.

Professor Karen Lam, Chairman of HKU-CTC, kick-started the ceremony by expressing her gratitude to all the stakeholders in clinical research during the welcoming address. Our guests of honour, Professor Sophia Chan, Secretary for Food and Health of the HKSAR Government, and Professor Paul Tam, Provost and Deputy Vice-Chancellor of HKU, highlighted the importance of clinical research to healthcare and scientific advancement and congratulated HKU-CTC’s contributions to the Hong Kong society and worldwide over the past 20 years.

A highlight of the evening was the interactive and interesting panel discussion featured by five distinguished HKU clinical researchers including (by alphabetical order of their last names) Professor Tak-Mao Chan, Professor Bernard Cheung, Professor Ching-Lung Lai, Professor Yu-Lung Lau and Professor Hextan Ngan, who together reviewed the history of clinical research over the past decades and shared their insights on the future research trends and opportunities for Hong Kong.

The society’s support is the key to the success of clinical research. We want to express our sincere gratitude to Baron Junior Music Academy, Theatre Cokida and Gingko House’s The Beginners Band – who showed their strong support to clinical research on behalf of different generations of Hong Kong people.